DK1183269T3 - Svækkede mikroorganismer til behandlingen af infektion - Google Patents
Svækkede mikroorganismer til behandlingen af infektionInfo
- Publication number
- DK1183269T3 DK1183269T3 DK00927538T DK00927538T DK1183269T3 DK 1183269 T3 DK1183269 T3 DK 1183269T3 DK 00927538 T DK00927538 T DK 00927538T DK 00927538 T DK00927538 T DK 00927538T DK 1183269 T3 DK1183269 T3 DK 1183269T3
- Authority
- DK
- Denmark
- Prior art keywords
- infection
- treatment
- attenuated microorganisms
- attenuated
- microorganisms
- Prior art date
Links
- 230000002238 attenuated effect Effects 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/255—Salmonella (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/42—Salmonella
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9910812.8A GB9910812D0 (en) | 1999-05-10 | 1999-05-10 | Vaccine composition |
PCT/GB2000/001749 WO2000068261A2 (en) | 1999-05-10 | 2000-05-09 | Attenuated microorganisms for the treatment of infection |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1183269T3 true DK1183269T3 (da) | 2007-04-02 |
Family
ID=10853168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00927538T DK1183269T3 (da) | 1999-05-10 | 2000-05-09 | Svækkede mikroorganismer til behandlingen af infektion |
Country Status (28)
Country | Link |
---|---|
US (3) | US6756042B1 (de) |
EP (2) | EP1183269B1 (de) |
JP (1) | JP4583607B2 (de) |
KR (2) | KR100680391B1 (de) |
CN (1) | CN1177863C (de) |
AP (1) | AP1470A (de) |
AT (2) | ATE346090T1 (de) |
AU (1) | AU763898B2 (de) |
BR (1) | BRPI0010418B8 (de) |
CA (1) | CA2372553C (de) |
CY (1) | CY1107656T1 (de) |
CZ (1) | CZ301926B6 (de) |
DE (2) | DE60031974T2 (de) |
DK (1) | DK1183269T3 (de) |
EA (1) | EA004921B1 (de) |
ES (1) | ES2277591T3 (de) |
GB (1) | GB9910812D0 (de) |
HU (1) | HUP0201117A3 (de) |
IL (3) | IL146255A0 (de) |
MA (1) | MA25411A1 (de) |
MX (1) | MXPA01011477A (de) |
NO (1) | NO329520B1 (de) |
NZ (1) | NZ539260A (de) |
OA (1) | OA11940A (de) |
PT (1) | PT1183269E (de) |
TR (1) | TR200702949T2 (de) |
WO (1) | WO2000068261A2 (de) |
ZA (1) | ZA200108912B (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1285960A3 (de) * | 1994-12-09 | 2003-05-07 | Imperial College Innovations Limited | Virulenzgene von Salmonella typhimurium |
ES2313792T3 (es) * | 1998-09-04 | 2009-03-01 | Emergent Product Development Uk Limited | Mutantes atenuados de spi2 de salmonella como portadores de antigeno. |
GB9910812D0 (en) * | 1999-05-10 | 1999-07-07 | Microscience Ltd | Vaccine composition |
GB0105924D0 (en) * | 2001-03-09 | 2001-04-25 | Microscience Ltd | Promoter |
US7449178B2 (en) * | 2002-04-05 | 2008-11-11 | Merial Limited | Attenuated gram negative bacteria |
US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
WO2008153772A2 (en) * | 2007-05-25 | 2008-12-18 | Emergent Product Development Gaithersburg Inc. | Chlamydia vaccine comprising htra polypeptides |
WO2009158240A1 (en) | 2008-06-16 | 2009-12-30 | Emergent Product Development Uk Limited | Salmonella vectored vaccines against chlamydia and methods of use |
WO2010017383A1 (en) | 2008-08-06 | 2010-02-11 | Emergent Product Development Uk Limited | Vaccines against clostridium difficile and methods of use |
US20120064114A1 (en) * | 2008-10-21 | 2012-03-15 | Emergent Product Development United Kingdom | Use of e. coli surface antigen 3 sequences for the export of heterologous antigens |
US8481052B2 (en) | 2011-05-17 | 2013-07-09 | Cj Cheiljedang Corporation | Avirulent Salmonella gallinarum variants and pharmaceutical composition using the same |
EP3552621A3 (de) * | 2013-10-11 | 2020-01-08 | Servizo Galego De Saúde (Sergas) | Attenuierte lebendimpfstoffe |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
EP3922255A1 (de) | 2020-06-10 | 2021-12-15 | Prokarium Limited | Krebstherapie |
EP4124342A1 (de) | 2021-07-28 | 2023-02-01 | Prokarium Limited | Krebstherapie mit lebenden attenuierten bakterien |
AU2022404718A1 (en) | 2021-12-09 | 2024-05-30 | Prokarium Limited | Combination cancer therapy |
WO2024061748A1 (en) | 2022-09-21 | 2024-03-28 | Prokarium Limited | Salmonella strain with chromosomally integrated landing pad |
GB202215134D0 (en) | 2022-10-13 | 2022-11-30 | Prokarium Ltd | Composition |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4440859A (en) * | 1977-05-27 | 1984-04-03 | The Regents Of The University Of California | Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms |
US4704362A (en) * | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
ES487106A0 (es) * | 1978-12-22 | 1981-05-16 | Biogen Nv | Un metodo para producir al menos un polipeptido que muestra antigenicidad de hbv |
US4530901A (en) * | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
US5210035A (en) * | 1980-05-19 | 1993-05-11 | Board Of Trustees Of Leland Stanford Jr. University | Non-reventing live vaccines |
US4550081A (en) * | 1980-05-19 | 1985-10-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Non-reverting salmonella |
US4837151A (en) * | 1980-05-19 | 1989-06-06 | The Board Of Trustees Of The Leland Stanford Junior University, Stanford University | Live vaccines comprising two mutations and foreign antigen |
US4766075A (en) * | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
US4582800A (en) * | 1982-07-12 | 1986-04-15 | Hoffmann-La Roche Inc. | Novel vectors and method for controlling interferon expression |
US4757006A (en) * | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
US4677063A (en) * | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
US5643579A (en) * | 1984-11-01 | 1997-07-01 | American Home Products Corporation | Oral vaccines |
US4810648A (en) * | 1986-01-08 | 1989-03-07 | Rhone Poulenc Agrochimie | Haloarylnitrile degrading gene, its use, and cells containing the gene |
US5397697A (en) * | 1989-01-10 | 1995-03-14 | Ciba-Geigy Corporation | Identification of plant-responsive genes of bacteria |
FR2664614B1 (fr) | 1990-07-11 | 1992-10-16 | Pasteur Institut | Sequences nucleiques issues du genome de salmonella typhi, et leurs utilisations notamment pour le diagnostic in vitro de la presence de bacteries du genre salmonella dans les produits alimentaires. |
SE9101433D0 (sv) | 1991-05-13 | 1991-05-13 | Marianne Hansson | Recombinant dna sequence and its use |
EP0669989A1 (de) | 1991-08-22 | 1995-09-06 | Washington University | Polynukleotid-Sonden für Salmonella |
AU2778992A (en) * | 1991-10-07 | 1993-05-03 | Idaho Research Foundation Inc., The | Genetic construct for selection of homologous recombinants on a single selective medium |
US5356797A (en) * | 1991-11-15 | 1994-10-18 | Board Of Regents, The University Of Texas | Membrane expression of heterologous genes |
WO1993010246A1 (en) | 1991-11-15 | 1993-05-27 | Board Of Regents, The University Of Texas System | Membrane expression of heterologous genes |
CA2148829A1 (en) | 1992-11-06 | 1994-05-26 | Keum Hwa Choi | Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis |
WO1994026933A1 (en) | 1993-05-13 | 1994-11-24 | The Board Of Trustees Of The Leland Stanford Junior University | Genetic footprinting: insertional mutagenesis and genetic selection |
WO1996011708A1 (en) | 1994-10-18 | 1996-04-25 | Board Of Regents, The University Of Texas System | Membrane expression of heterologous genes |
EP1285960A3 (de) * | 1994-12-09 | 2003-05-07 | Imperial College Innovations Limited | Virulenzgene von Salmonella typhimurium |
US5700683A (en) * | 1995-02-17 | 1997-12-23 | Pathogenesis Corporation | Virulence-attenuating genetic deletions deleted from mycobacterium BCG |
EP0857214A1 (de) * | 1995-10-16 | 1998-08-12 | Smithkline Beecham Plc | Neuartiges speichel-bindendes protein |
CA2237581A1 (en) | 1995-11-14 | 1997-05-22 | The General Hospital Corporation | Salmonella secreted proteins and uses thereof |
US6030624A (en) | 1996-08-16 | 2000-02-29 | Uab Research Foundation | Mucosal immunogens for novel vaccines |
GB9621091D0 (en) * | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
CA2280839A1 (en) | 1997-02-14 | 1998-08-20 | Merck & Co., Inc. | Polynucleotide vaccine formulations |
US6455323B1 (en) | 1997-07-03 | 2002-09-24 | Pharmacia & Upjohn Company | Anti-bacterial methods and materials |
GB9804809D0 (en) | 1998-03-06 | 1998-04-29 | Wallis Timothy S | Attenuated salmonella:materials and methods relating thereto |
US6585975B1 (en) * | 1998-04-30 | 2003-07-01 | Acambis, Inc. | Use of Salmonella vectors for vaccination against helicobacter infection |
ES2313792T3 (es) * | 1998-09-04 | 2009-03-01 | Emergent Product Development Uk Limited | Mutantes atenuados de spi2 de salmonella como portadores de antigeno. |
US6846667B1 (en) * | 1998-11-09 | 2005-01-25 | Microscience, Ltd. | Virulence genes and proteins, and their use |
GB9910812D0 (en) * | 1999-05-10 | 1999-07-07 | Microscience Ltd | Vaccine composition |
WO2001032697A2 (en) | 1999-11-05 | 2001-05-10 | L'unite De Recherche En Biologie Moleculaire (Urbm) Des Facultes Universitaires Notre Dame De La Paix (Fundp) | Virulence genes and proteins from brucella melitensis, and their use |
JP3414342B2 (ja) * | 1999-11-25 | 2003-06-09 | 日本電気株式会社 | 集積回路チップの実装構造および実装方法 |
NZ519669A (en) * | 1999-12-23 | 2004-03-26 | Vmax Ltd | Streptococcus pyogenes virulence genes and proteins and their use |
GB0011108D0 (en) | 2000-05-08 | 2000-06-28 | Microscience Ltd | Virulence gene and protein and their use |
GB0127657D0 (en) | 2001-11-19 | 2002-01-09 | Microscience Ltd | Virulence genes and proteins and their use |
US7449178B2 (en) * | 2002-04-05 | 2008-11-11 | Merial Limited | Attenuated gram negative bacteria |
-
1999
- 1999-05-10 GB GBGB9910812.8A patent/GB9910812D0/en not_active Ceased
-
2000
- 2000-05-09 DK DK00927538T patent/DK1183269T3/da active
- 2000-05-09 IL IL14625500A patent/IL146255A0/xx active IP Right Grant
- 2000-05-09 CN CNB00808419XA patent/CN1177863C/zh not_active Expired - Fee Related
- 2000-05-09 US US09/569,601 patent/US6756042B1/en not_active Expired - Lifetime
- 2000-05-09 DE DE60031974T patent/DE60031974T2/de not_active Expired - Lifetime
- 2000-05-09 DE DE60043868T patent/DE60043868D1/de not_active Expired - Lifetime
- 2000-05-09 AT AT00927538T patent/ATE346090T1/de active
- 2000-05-09 HU HU0201117A patent/HUP0201117A3/hu not_active Application Discontinuation
- 2000-05-09 JP JP2000616235A patent/JP4583607B2/ja not_active Expired - Fee Related
- 2000-05-09 NZ NZ539260A patent/NZ539260A/en not_active IP Right Cessation
- 2000-05-09 ES ES00927538T patent/ES2277591T3/es not_active Expired - Lifetime
- 2000-05-09 WO PCT/GB2000/001749 patent/WO2000068261A2/en active Application Filing
- 2000-05-09 EP EP00927538A patent/EP1183269B1/de not_active Expired - Lifetime
- 2000-05-09 CZ CZ20014030A patent/CZ301926B6/cs not_active IP Right Cessation
- 2000-05-09 OA OA1200100295A patent/OA11940A/en unknown
- 2000-05-09 PT PT00927538T patent/PT1183269E/pt unknown
- 2000-05-09 EA EA200101187A patent/EA004921B1/ru not_active IP Right Cessation
- 2000-05-09 TR TR2007/02949T patent/TR200702949T2/xx unknown
- 2000-05-09 AU AU45932/00A patent/AU763898B2/en not_active Ceased
- 2000-05-09 AT AT06012488T patent/ATE457998T1/de not_active IP Right Cessation
- 2000-05-09 BR BRPI0010418A patent/BRPI0010418B8/pt not_active IP Right Cessation
- 2000-05-09 KR KR1020017014154A patent/KR100680391B1/ko not_active IP Right Cessation
- 2000-05-09 KR KR1020067018279A patent/KR100811319B1/ko not_active IP Right Cessation
- 2000-05-09 AP APAP/P/2001/002317A patent/AP1470A/en active
- 2000-05-09 MX MXPA01011477A patent/MXPA01011477A/es active IP Right Grant
- 2000-05-09 CA CA2372553A patent/CA2372553C/en not_active Expired - Fee Related
- 2000-05-09 EP EP06012488A patent/EP1702927B1/de not_active Expired - Lifetime
-
2001
- 2001-10-29 ZA ZA200108912A patent/ZA200108912B/xx unknown
- 2001-10-31 IL IL146255A patent/IL146255A/en not_active IP Right Cessation
- 2001-11-08 NO NO20015464A patent/NO329520B1/no not_active IP Right Cessation
- 2001-11-09 MA MA26404A patent/MA25411A1/fr unknown
-
2004
- 2004-04-08 US US10/822,053 patent/US7211264B2/en not_active Expired - Lifetime
-
2006
- 2006-12-21 CY CY20061101836T patent/CY1107656T1/el unknown
-
2007
- 2007-02-01 US US11/701,214 patent/US7887816B2/en not_active Expired - Fee Related
- 2007-10-29 IL IL186993A patent/IL186993A/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1183269T3 (da) | Svækkede mikroorganismer til behandlingen af infektion | |
DK1459749T3 (da) | (S,S)-reboxetin til behandling af inkontinens | |
DK2412368T3 (da) | Sammensætning til behandling af ar | |
DK1173059T3 (da) | Fremgangsmåde til forögelse af biologisk virkningsfuldhed af plantebehandlingssammensætninger | |
DK1147083T3 (da) | Arylpiperazinyl-cyclohexylindolderivater til behandling af depression | |
DK1144395T3 (da) | 2-amino-benzoxazinon-derivater til behandling af fedme | |
DE60133159D1 (de) | Vakuumbehandlungsanlage | |
DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
DK0965566T3 (da) | Fremgangsmåde til behandling af organisk spildevand | |
DE60021065D1 (de) | Virus behandlung | |
ATE253578T1 (de) | Oxazinochinolone zur behandlung von viralen infektionen | |
NO20013596L (no) | Slambehandling | |
NO20022949D0 (no) | Attenuerte mikroorganismer for behandling av infeksjon | |
DK1268482T3 (da) | Pyranoindoler til behandling af glaukom | |
NO20032769L (no) | Kombinasjonsmetode for behandling av virale infeksjoner | |
DK1493442T3 (da) | Reboxetin til behandling af perifer neuropati | |
ATE267598T1 (de) | Virus behandlung | |
ATA10412001A (de) | Kleinkläranlage | |
DK9900121Y6 (da) | Minirensningsanlæg | |
ATA190699A (de) | Abwasserreinigungsanlage | |
AU2003204710A1 (en) | Attenuated microorganisms for the treatment of infection | |
FI990339A0 (fi) | Jätevedenpienpuhdistamo | |
ATA682000A (de) | Kläranlage | |
EE200000017A (et) | Reoveepuhasti |